Kateryna Shmanko

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy – development and validation of the CRAFITY score

Bernhard Scheiner, Katharina Pomej, Martha M. Kirstein et al. · Journal of Hepatology · 2021 · 300 citations · Full text

Pharmacy, Immunology, Oncology +17

Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience

Tiago B. R. Castro, Leonie Jochheim, Melanie Bathon et al. · Therapeutic Advances in Medical Oncology · 2022 · 79 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

Bernhard Scheiner, Daniel Roessler, Samuel Phen et al. · JHEP Reports · 2022 · 61 citations · Full text

Medicine, Immunology, Oncology +14

Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study

Sabrina Welland, Catherine Leyh, Fabian Finkelmeier et al. · Liver Cancer · 2022 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Clinical characteristics and outcome of patients with combined hepatocellular-cholangiocarcinoma—a European multicenter cohort

Katharina Pomej, Lorenz Balcar, Kateryna Shmanko et al. · ESMO Open · 2023 · 19 citations · Full text

Medicine, Oncology, Pathology +13